# Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe

> **NCT04589351** · PHASE3 · UNKNOWN · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetic Kidney Disease

## Interventions

- **DRUG:** Ezetimibe 10mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04589351
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-05
- **Final completion:** 2022-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-01-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04589351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04589351, "Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04589351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*